ArticleCell biology and toxicology2020
How to breakthrough mitochondrial DNA methylation-associated networks.
Article in Cell biology and toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 11 citations in OpenAlex.
- Mitochondrial DNA methylation: State-of-the-art in molecular mechanisms and disease implications.Journal of advanced research · 2026Review
- Diagnostic and therapeutic innovations in myocardial infarction: a focus on mitochondrial dysfunction.Frontiers in cardiovascular medicine · 2026Review
- Aging through the lens of mitochondrial DNA mutations and inheritance paradoxes.Biogerontology · 2024Review
- Targeted Mitochondrial Epigenetics: A New Direction in Alzheimer's Disease Treatment.International journal of molecular sciences · 2022Review
- Article
- Clinical challenges of tissue preparation for spatial transcriptome.Clinical and translational medicine · 2022Article
- Potential biomarkers and targets of mitochondrial dynamics.Clinical and translational medicine · 2021Review
- Trans-omic profiling between clinical phenoms and lipidomes among patients with different subtypes of lung cancer.Clinical and translational medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mitochondrial DNA (mtDNA) plays an important role in regulating mitochondrial homeostasis, transcription, cell metabolism, and drug sensitivity. Patterns and regulations of mtDNA methylation vary among cell types, species, functions, and diseases. High-resolution mtDNA methylation maps of human and animal mitochondrial genomes addressed that the light (L)-strand non-CpG methylation of mtDNA varied among species, developing stages, and ages. Of DNA methyltransferases, DNMT3A was a critical enzyme in the dynamic regulation of mtDNA regional methylation patterns and strand bias. Altered mtDNA methylations may regulate dynamic occurrences of pathogenic mtDNA mutations. The number and sites of control regions, involved enzymes, and regulators during mtDNA methylation may vary among cell types and diseases. Specific regulatory and functional networks associated with mtDNA methylation mainly include mtDNA, regulatory factors, methyltransferases, nucleotides, mt-rRNAs, and other epigenetic modifications. Those carry out precise functions and regulations of mtDNA methylation-associated network, interactions with genome DNA and other signal pathways, and decisive roles in patient phenomes. A breakthrough in mtDNA methylation-associated networks will be a crucial milestone in the journey of understanding mitochondrial function at a higher level and discovering new mitochondria-based biomarkers and therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.